Blood News and Research

RSS

Neutrolis announces development of first-in-class therapy to target NETs in COVID-19 patients

Neutrolis, a biotechnology company developing therapeutics that target neutrophils, the most abundant immune cells in the body, today announced the development of NTR-441, a first-in-class DNASE1L3 enzyme analog that has the potential to rapidly and systemically clear neutrophil extracellular traps for severe cases of COVID-19.

5 Aug 2020

Embryos are susceptible to COVID-19 if mothers get sick, indicates study

Genes that are thought to play a role in how the SARS-CoV-2 virus infects our cells have been found to be active in embryos as early as during the second week of pregnancy, say scientists at the University of Cambridge and the California Institute of Technology (Caltech).

5 Aug 2020

Osteopore announces success of its 3D-printed PCL bone implant in cranioplasty procedure

Osteopore International Pte Ltd, a Singapore-headquartered company leading the way in regenerative bone implants, is proud to announce the success of its technology in a new medical procedure that took place in Brisbane, Australia, in December last year.

5 Aug 2020

Scientists detect emergence and spread of artemisinin-resistant malaria parasites in Rwanda

Resistance to artemisinin, the main component of the current antimalarial treatments recommended by WHO, is already widespread in South-East Asia, but it had not previously been described in Africa.

5 Aug 2020

SNIS 17th Annual Meeting highlights COVID-19 and racial disparities in stroke treatment

The next frontier in neurointerventional surgery, including advances in stroke triage and management, innovations in artificial intelligence and robotics in endovascular surgery, new findings on racial disparities in stroke treatment and the neurologic impact of COVID-19 are a few of the topics that will be covered at the Society of NeuroInterventional Surgery's (SNIS) 17th Annual Meeting taking place virtually August 4-7, 2020.

5 Aug 2020

De novo protein decoys that block SARS-CoV-2

Now, a new study published on the preprint server bioRxiv in August 2020 shows that computational design technology can be efficiently harnessed towards this end, producing new molecules to inhibit viral entry and replication.

5 Aug 2020

Novel technology tests the presence of thin membrane protrusions on breast cancer cells

Researchers at the University of Maryland School of Medicine (UMSOM) have developed a novel technology to test for the presence of thin membrane protrusions called "microtentacles" on breast cancer cells, which can help predict whether a tumor is likely to spread.

5 Aug 2020

Researchers use microscopy technique to predict the course of lung cancer

Both in the periphery and the center of lung tumors, characteristic accumulations of certain white blood cells, known as macrophages, are often found. In this case they are called tumor-associated macrophages.

5 Aug 2020

NCI gives 'exceptional' rating to Penn's Abramson Cancer Center

The National Cancer Institute has once again rated the Abramson Cancer Center of the University of Pennsylvania as "exceptional," the highest possible rating for an NCI-designated comprehensive cancer center.

4 Aug 2020

ACTG initiates novel clinical trial to evaluate multiple therapeutics for COVID-19

The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, which will be conducted by the ACTG.

4 Aug 2020

Disruptions to lipid metabolism after childbirth predict future diabetes risk

Scientists have found that disruptions to the metabolism of lipids occur after childbirth in women with gestational diabetes who go on to develop type 2 diabetes.

4 Aug 2020

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

A Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies (mAbs) to treat the disease.

4 Aug 2020

Genetic variation influencing chromatin states associated with neuropsychiatric disorders

A new study led by NorthShore University HealthSystem and the University of Chicago took a novel approach to identifying SNPs influencing the risk of neuropsychiatric disorders like schizophrenia, bipolar and major depressive disorder, the institutions announced today.

4 Aug 2020

Decoy receptor neutralizes SARS-CoV-2 virus in tissue cultures

As the COVID-19 pandemic continues to spread, scientists and health care providers are seeking ways to keep the coronavirus from infecting tissues once they're exposed. A new study suggests luring the virus with a decoy - an engineered, free-floating receptor protein - binds the virus and blocks infection.

4 Aug 2020

Study identifies impact of gene mutations on severity of myelodysplastic syndrome

The Myelodysplastic Syndromes Group of Josep Carreras Leukaemia Research Institute, led by Dr. Francesc Solé, has participated in the first international study that confirms that having two mutated copies of the TP53 gene, as opposed to a single mutated copy, is associated with a worse prognosis in patients diagnosed with myelodysplastic syndrome (MDS).

4 Aug 2020

New iron intervention study fights anemia with advanced computer simulation

A new iron intervention study has determined which of the world's low-and-middle income countries would benefit from using iron-containing micronutrient powders to tackle childhood anaemia.

4 Aug 2020

CNIO and HKUST researchers identify how some gliomas acquire chemoresistance

A team led by Massimo Squatrito, Head of the Seve Ballesteros Foundation Brain Tumour Group at the Spanish National Cancer Research Centre, have made important findings of how some gliomas can acquire chemoresistance.

4 Aug 2020

HIIT helps achieve critical health outcomes for individuals with Down syndrome

Incorporating high-intensity interval training, or HIIT, into exercise programs for individuals with Down syndrome may help achieve critical health outcomes in a more time-efficient manner, according to an article written by researchers at the University of Georgia and Kennesaw State University.

4 Aug 2020

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.

4 Aug 2020

Researcher is exploring safer and more effective treatment for leukemia

A potentially safer, more effective chemotherapy treatment for patients with blood-related cancers, such as leukemia, who need a particular bone marrow transplant procedure is under study at the University of Arizona Health Sciences.

4 Aug 2020

Blood News and Research

Neutrolis announces development of first-in-class therapy to target NETs in COVID-19 patients

Embryos are susceptible to COVID-19 if mothers get sick, indicates study

Osteopore announces success of its 3D-printed PCL bone implant in cranioplasty procedure

Scientists detect emergence and spread of artemisinin-resistant malaria parasites in Rwanda

SNIS 17th Annual Meeting highlights COVID-19 and racial disparities in stroke treatment

De novo protein decoys that block SARS-CoV-2

Novel technology tests the presence of thin membrane protrusions on breast cancer cells

Researchers use microscopy technique to predict the course of lung cancer

NCI gives 'exceptional' rating to Penn's Abramson Cancer Center

ACTG initiates novel clinical trial to evaluate multiple therapeutics for COVID-19

Disruptions to lipid metabolism after childbirth predict future diabetes risk

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

Genetic variation influencing chromatin states associated with neuropsychiatric disorders

Decoy receptor neutralizes SARS-CoV-2 virus in tissue cultures

Study identifies impact of gene mutations on severity of myelodysplastic syndrome

New iron intervention study fights anemia with advanced computer simulation

CNIO and HKUST researchers identify how some gliomas acquire chemoresistance

HIIT helps achieve critical health outcomes for individuals with Down syndrome

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

Researcher is exploring safer and more effective treatment for leukemia

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News